Historical Valuation
GALAXY ENT (00027) is now in the Fair zone, suggesting that its current forward PS ratio of 3.39 is considered Fairly compared with the five-year average of 35.08. The fair price of GALAXY ENT (00027) is between 25.67 to 92.81 according to relative valuation methord.
Relative Value
Fair Zone
25.67-92.81
Current Price：40.68
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
GALAXY ENT (00027) has a current Price-to-Book (P/B) ratio of 2.08. Compared to its 3-year average P/B ratio of 2.46 , the current P/B ratio is approximately -15.37% higher. Relative to its 5-year average P/B ratio of 2.78, the current P/B ratio is about -25.15% higher. GALAXY ENT (00027) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.90%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.03% , the current FCF yield is about -100.00% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of 00027 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 00027 in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is 00027 currently overvalued or undervalued?
GALAXY ENT (00027) is now in the Fair zone, suggesting that its current forward PS ratio of 3.39 is considered Fairly compared with the five-year average of 35.08. The fair price of GALAXY ENT (00027) is between 25.67 to 92.81 according to relative valuation methord.
What is GALAXY ENT (00027) fair value?
00027's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of GALAXY ENT (00027) is between 25.67 to 92.81 according to relative valuation methord.
How does 00027's valuation metrics compare to the industry average?
The average P/S ratio for 00027's competitors is , providing a benchmark for relative valuation. GALAXY ENT Corp (00027) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for GALAXY ENT (00027) as of Jan 15 2026?
As of Jan 15 2026, GALAXY ENT (00027) has a P/B ratio of 2.08. This indicates that the market values 00027 at 2.08 times its book value.
What is the current FCF Yield for GALAXY ENT (00027) as of Jan 15 2026?
As of Jan 15 2026, GALAXY ENT (00027) has a FCF Yield of 0.00%. This means that for every dollar of GALAXY ENT’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for GALAXY ENT (00027) as of Jan 15 2026?
As of Jan 15 2026, GALAXY ENT (00027) has a Forward P/E ratio of 14.80. This means the market is willing to pay $14.80 for every dollar of GALAXY ENT’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for GALAXY ENT (00027) as of Jan 15 2026?
As of Jan 15 2026, GALAXY ENT (00027) has a Forward P/S ratio of 3.39. This means the market is valuing 00027 at $3.39 for every dollar of expected revenue over the next 12 months.